In- and out-licensing in China: A guide to success

Apr 23, 2015 Tags: Biotech Business development

Chinese in- and out-licensing deals are jumping to new record levels. For Western companies, in-licensing assets to the Chinese market creates a great opportunity to enter this exciting market. Despite hurdles to be overcome for success in China, these companies successfully navigate the process with the right partner. For Chinese companies, the option to out-license their assets creates significant leverage with the Western life science industry.

Moderator: Alicia Hong, LLM – Dechert LLP